Suppr超能文献

HIV 感染者的肝脏疾病。

Liver disease in the HIV-infected individual.

机构信息

Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland 21287, USA.

出版信息

Clin Gastroenterol Hepatol. 2010 Dec;8(12):1002-12. doi: 10.1016/j.cgh.2010.08.024. Epub 2010 Sep 17.

Abstract

Since the advent of effective antiretroviral therapy (ART) for human immunodeficiency virus-1 (HIV), there has been a substantial decrease in deaths related to acquired immunodeficiency syndrome (AIDS). However, in the ART era, liver disease is now the most common non-AIDS-related cause of death among HIV-infected patients, accounting for 14%-18% of all deaths in this population and almost half of deaths among hospitalized HIV-infected patients. Just as the burden of non-AIDS morbidity and mortality has changed in the ART era, the types of liver disease the clinician is likely to encounter among these patients have changed as well. This review will discuss the causes of liver disease in the HIV-infected population in the ART era, including chronic hepatitis C virus, chronic hepatitis B virus, medication-related hepatotoxicity, alcohol abuse, nonalcoholic fatty liver disease, and AIDS-related liver diseases.

摘要

自人类免疫缺陷病毒 1(HIV)有效的抗逆转录病毒疗法(ART)问世以来,与获得性免疫缺陷综合征(AIDS)相关的死亡人数大幅下降。然而,在 ART 时代,肝脏疾病现在是 HIV 感染患者中最常见的非 AIDS 相关死亡原因,占该人群所有死亡人数的 14%-18%,几乎占住院 HIV 感染患者死亡人数的一半。就像在 ART 时代非 AIDS 发病率和死亡率的负担发生了变化一样,临床医生在这些患者中可能遇到的肝脏疾病类型也发生了变化。本文将讨论在 ART 时代 HIV 感染人群中肝脏疾病的病因,包括慢性丙型肝炎病毒、慢性乙型肝炎病毒、药物相关肝毒性、酒精滥用、非酒精性脂肪性肝病和 AIDS 相关肝病。

相似文献

1
Liver disease in the HIV-infected individual.
Clin Gastroenterol Hepatol. 2010 Dec;8(12):1002-12. doi: 10.1016/j.cgh.2010.08.024. Epub 2010 Sep 17.
2
Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons.
Clin Gastroenterol Hepatol. 2010 Feb;8(2):183-91. doi: 10.1016/j.cgh.2009.09.025. Epub 2009 Oct 2.
3
Antiretroviral Therapies for Human Immunodeficiency Virus and Liver Disease: Challenges and opportunities.
Ann Hepatol. 2020 Mar-Apr;19(2):121-122. doi: 10.1016/j.aohep.2020.02.004.
4
The burden of liver disease in human immunodeficiency virus-infected patients.
Semin Liver Dis. 2012 May;32(2):103-13. doi: 10.1055/s-0032-1316473. Epub 2012 Jul 3.
5
Increasing burden of liver disease in patients with HIV infection.
Lancet. 2011 Apr 2;377(9772):1198-209. doi: 10.1016/S0140-6736(10)62001-6.
7
Liver involvement in human immunodeficiency virus infection.
Indian J Gastroenterol. 2016 Jul;35(4):260-73. doi: 10.1007/s12664-016-0666-8. Epub 2016 Jun 3.
9
Comparison of deaths related to Hepatitis C and AIDS in Scotland.
J Viral Hepat. 2007 Dec;14(12):870-4. doi: 10.1111/j.1365-2893.2007.00876.x.
10
Survival of HIV-infected patients with compensated liver cirrhosis.
AIDS. 2010 Mar 13;24(5):745-53. doi: 10.1097/QAD.0b013e3283366602.

引用本文的文献

1
Trends and disparities in human immunodeficiency virus and chronic liver disease mortality in the United States: A nationwide analysis.
J Int Med Res. 2025 Aug;53(8):3000605251363782. doi: 10.1177/03000605251363782. Epub 2025 Aug 9.
3
The global prevalence and impact of steatotic liver disease and viral infections: A systematic review and meta-analysis.
Hepatol Commun. 2025 Apr 14;9(5). doi: 10.1097/HC9.0000000000000689. eCollection 2025 May 1.
4
Pharmacokinetics of islatravir in participants with moderate hepatic impairment.
Antimicrob Agents Chemother. 2025 Apr 2;69(4):e0155324. doi: 10.1128/aac.01553-24. Epub 2025 Mar 5.
5
The clinical indexes and immunological status of HIV/AIDS patients undergoing different highly active antiretroviral treatments.
Front Cell Infect Microbiol. 2024 Dec 17;14:1436123. doi: 10.3389/fcimb.2024.1436123. eCollection 2024.
6
Non-alcoholic fatty liver disease among people living with HIV on long-term antiretroviral therapy in Indonesia: Prevalence and related factors.
SAGE Open Med. 2024 Dec 18;12:20503121241292678. doi: 10.1177/20503121241292678. eCollection 2024.
7
Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancer.
Am J Prev Cardiol. 2024 Oct 28;20:100888. doi: 10.1016/j.ajpc.2024.100888. eCollection 2024 Dec.
8
Risk factors associated with post-tuberculosis sequelae: a systematic review and meta-analysis.
EClinicalMedicine. 2024 Oct 21;77:102898. doi: 10.1016/j.eclinm.2024.102898. eCollection 2024 Nov.
10
Hepatitis B and C Virus Co-Infection and Their Association With Liver Disease in Persons With HIV in Nigeria.
J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241292511. doi: 10.1177/23259582241292511.

本文引用的文献

1
2
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study.
AIDS. 2010 Jun 19;24(10):1537-48. doi: 10.1097/QAD.0b013e32833a0918.
6
Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons.
Clin Gastroenterol Hepatol. 2010 Feb;8(2):183-91. doi: 10.1016/j.cgh.2009.09.025. Epub 2009 Oct 2.
8
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.
Nature. 2009 Sep 17;461(7262):399-401. doi: 10.1038/nature08309. Epub 2009 Aug 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验